CSI FOCUS D-HF: Neuromodulation in the management of heart failure and its comorbidities: diabetes, sleep apnea and hypertension
Moderators: Howard Levin, Felix Mahfoud
Moderators
- Howard Levin, Coridea, New York, USA
- Felix Mahfoud, Saarland University Hospital, Homburg, Germany
Q&A moderators
- Marat Fudim, Duke University and the Duke Clinical Research Institute, Durham, USA
- Shakeel Qureshi, Evelina Children's Hospital, London, United Kingdom
Panelists
- Michael Böhm, Saarland University Hospital, Homburg, Germany
- Marshall Heradien, Stellenbosch University, Cape Town, South Africa
- William Abraham, Ohio State University, Columbus, USA
- Jörn Schmitt, University of Gießen, Gießen, Germany
- Horst Sievert, CardioVascular Center Frankfurt CVC, Frankfurt, Germany
- Daniel Burkhoff, Cardiovascular Research Foundation, New York, USA
- Joachim Ehrlich, St. Josefs-Hospital, Wiesbaden, Germany
Program
The top heart failure target for renal denervation...
- … should be HFpEFMichael Böhm
- … should be HFrEFMarat Fudim
- … should be arrhythmiasMarshall Heradien
- Phrenic nerve stimulation with the Remede systemWilliam Abraham
- BAROSTIM to treat HFrEF – Approved therapy for an unmet need!Jörn Schmitt
- Endovascular ablation of the right greater splanchnic nerveHorst Sievert
- BackbeatDaniel Burkhoff
- Cardiac contractility modulation - How it worksJoachim Ehrlich
- An endovascular approach to Baroreflex neuromodulationHorst Sievert
Supported by
Accreditation
The webinar was accredited by the European Board for Accreditation in Cardiology (EBAC) with 2 CME credits.